(VIANEWS) - Calamos Global Total Return Fund (CGO), Cohen & Steers Infrastructure Fund (UTF), NVE Corporation (NVEC) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Calamos Global Total Return Fund (CGO) | 15.39 | -0.29% | 7.67% | 2022-01-05 13:43:13 |
| 2 | Cohen & Steers Infrastructure Fund (UTF) | 28.92 | 1.47% | 6.53% | 2022-01-04 05:11:06 |
| 3 | NVE Corporation (NVEC) | 66.78 | -1.4% | 5.88% | 2022-01-09 11:49:12 |
| 4 | Elbit Imaging Ltd. (EMITF) | 1.85 | 0% | 4.26% | 2022-01-06 09:08:06 |
| 5 | Pioneer Municipal High Income Advantage Trust (MAV) | 11.55 | 0.09% | 4.16% | 2022-01-02 01:55:09 |
| 6 | Boulder Growth & Income Fund (BIF) | 13.97 | 0.9% | 2.94% | 2021-12-30 23:48:15 |
| 7 | Fresenius Medical Care AG (FMS) | 33.80 | 2.42% | 2.3% | 2022-01-14 18:06:58 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Calamos Global Total Return Fund (CGO) - Dividend Yield: 7.67%
Calamos Global Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in equities, convertible bonds, and high yield corporate bonds. It employs both fundamental and quantitative analysis to create its portfolio. The fund benchmarks the performance of its portfolio against MSCI World Index. Calamos Global Total Return Fund was formed on March 30, 2004 and is domiciled in the United States.
Volume
Today's last reported volume for Calamos Global Total Return Fund is 13633, 41.15% below its average volume of 23165.
Calamos Global Total Return Fund's last close was $15.42, 11.73% under its 52-week high of $17.47.
Calamos Global Total Return Fund's Revenue
Year-on-year quarterly revenue growth declined by 21.5%, now sitting on 3.82M for the twelve trailing months.
Calamos Global Total Return Fund's Stock Yearly Top and Bottom Value
Calamos Global Total Return Fund's stock is valued at $15.39 at 19:15 EST, way under its 52-week high of $17.47 and above its 52-week low of $14.24.
Calamos Global Total Return Fund's Moving Average
Calamos Global Total Return Fund's value is below its 50-day moving average of $15.70 and under its 200-day moving average of $15.95.More news about Calamos Global Total Return Fund.
2. Cohen & Steers Infrastructure Fund (UTF) - Dividend Yield: 6.53%
Cohen & Steers Infrastructure Fund, Inc. is a closed-end equity fund launched by Cohen & Steers, Inc. The fund is managed by Cohen & Steers Capital Management, Inc. It invests in public equity markets of the United States. The fund invests primarily in value stocks of infrastructure companies across all market capitalizations. It employs fundamental analysis to make its investments. The fund benchmarks the performance of its portfolio against a composite index of 80% FTSE Global Core Infrastructure 50/50 Net Tax Index (FTSE 50/50) and 20% BofA Merrill Lynch Fixed-Rate Preferred Securities Index. It was formerly known as Cohen & Steers Select Utility Fund, Inc. Cohen & Steers Infrastructure Fund, Inc. was formed on January 8, 2004 and is domiciled in the United States.
Volume
Today's last reported volume for Cohen & Steers Infrastructure Fund is 344486, 143.24% above its average volume of 141622.
Cohen & Steers Infrastructure Fund's last close was $28.92, 3.44% under its 52-week high of $29.95.
Cohen & Steers Infrastructure Fund's Revenue
Year-on-year quarterly revenue growth declined by 2.3%, now sitting on 93.91M for the twelve trailing months.
Cohen & Steers Infrastructure Fund's Stock Yearly Top and Bottom Value
Cohen & Steers Infrastructure Fund's stock is valued at $28.92 at 19:15 EST, below its 52-week high of $29.95 and way higher than its 52-week low of $24.81.
Cohen & Steers Infrastructure Fund's Moving Average
Cohen & Steers Infrastructure Fund's worth is above its 50-day moving average of $28.03 and above its 200-day moving average of $28.34.More news about Cohen & Steers Infrastructure Fund.
3. NVE Corporation (NVEC) - Dividend Yield: 5.88%
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data. Its products comprise standard sensors to detect the presence of a magnetic or metallic material to determine position or speed primarily for the factory automation market; and custom and medical sensors for medical devices to replace electromechanical magnetic switches. The company also offers spintronic couplers for industrial Internet of Things market. In addition, it engages in the research and development, and licensing of spintronic magnetoresistive random access memory technology. NVE Corporation was founded in 1989 and is headquartered in Eden Prairie, Minnesota.
Volume
Today's last reported volume for NVE Corporation is 15431, 19.43% below its average volume of 19153.
NVE Corporation's last close was $66.78, 17.98% under its 52-week high of $81.42.
NVE Corporation's Revenue
Year-on-year quarterly revenue growth grew by 55.8%, now sitting on 26.37M for the twelve trailing months.
NVE Corporation's Stock Yearly Top and Bottom Value
NVE Corporation's stock is valued at $66.78 at 19:15 EST, way under its 52-week high of $81.42 and higher than its 52-week low of $62.07.
NVE Corporation's Moving Average
NVE Corporation's worth is under its 50-day moving average of $69.37 and below its 200-day moving average of $70.19.More news about NVE Corporation.
4. Elbit Imaging Ltd. (EMITF) - Dividend Yield: 4.26%
Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.
Volume
Today's last reported volume for Elbit Imaging Ltd. is 1300, 1.17% above its average volume of 1285.
Elbit Imaging Ltd.'s last close was $1.85, 31.99% under its 52-week high of $2.72.
Elbit Imaging Ltd.'s Stock Yearly Top and Bottom Value
Elbit Imaging Ltd.'s stock is valued at $1.85 at 19:15 EST, way below its 52-week high of $2.72 and way above its 52-week low of $1.37.
Elbit Imaging Ltd.'s Moving Average
Elbit Imaging Ltd.'s worth is higher than its 50-day moving average of $1.79 and under its 200-day moving average of $2.03.More news about Elbit Imaging Ltd..
5. Pioneer Municipal High Income Advantage Trust (MAV) - Dividend Yield: 4.16%
Pioneer Municipal High Income Advantage Trust is a closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. The fund invests in the fixed income markets of the United States. It invests primarily in municipal bonds. The fund benchmarks the performance of its portfolio against the Barclays Capital High Yield Municipal Bond Index and the Barclays Capital Municipal Bond Index. It was formerly known as Pioneer Municipal Advantage Trust. Pioneer Municipal High Income Advantage Trust was formed on August 6, 2003 and is domiciled in the United States.
Volume
Today's last reported volume for Pioneer Municipal High Income Advantage Trust is 125406, 98.51% above its average volume of 63173.
Pioneer Municipal High Income Advantage Trust's last close was $11.55, 11.02% below its 52-week high of $12.98.
Pioneer Municipal High Income Advantage Trust's Revenue
Year-on-year quarterly revenue growth declined by 4.4%, now sitting on 17.42M for the twelve trailing months.
Pioneer Municipal High Income Advantage Trust's Stock Yearly Top and Bottom Value
Pioneer Municipal High Income Advantage Trust's stock is valued at $11.55 at 19:15 EST, way under its 52-week high of $12.98 and above its 52-week low of $11.28.
Pioneer Municipal High Income Advantage Trust's Moving Average
Pioneer Municipal High Income Advantage Trust's worth is below its 50-day moving average of $11.75 and below its 200-day moving average of $12.01.More news about Pioneer Municipal High Income Advantage Trust.
6. Boulder Growth & Income Fund (BIF) - Dividend Yield: 2.94%
Boulder Growth & Income Fund, Inc. is a closed-ended balanced mutual fund launched and managed by Boulder Investment Advisers, L.L.C. It is co-managed by Stewart West Indies Trading Co Ltd. and Rocky Mountain Advisers, Llc. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified industries. The fund primarily invests in dividend paying value stocks of companies across all capitalizations, as well as in fixed income securities issued by companies. It employs both fundamental and quantitative analysis with a bottom-up security picking approach, focusing on such factors as defensible businesses with solid financial positions and strong operating track records to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Composite Index. Boulder Growth & Income Fund, Inc. was formed on December 7, 1972 and is domiciled in the United States.
Volume
Today's last reported volume for Boulder Growth & Income Fund is 44512, 56.6% below its average volume of 102569.
Boulder Growth & Income Fund's last close was $14.21, 1.25% under its 52-week high of $14.39.
Boulder Growth & Income Fund's Revenue
Year-on-year quarterly revenue growth grew by 13.8%, now sitting on 22.51M for the twelve trailing months.
Boulder Growth & Income Fund's Stock Yearly Top and Bottom Value
Boulder Growth & Income Fund's stock is valued at $13.97 at 19:15 EST, under its 52-week high of $14.39 and way higher than its 52-week low of $10.91.
Boulder Growth & Income Fund's Moving Average
Boulder Growth & Income Fund's worth is higher than its 50-day moving average of $13.48 and higher than its 200-day moving average of $13.45.More news about Boulder Growth & Income Fund.
7. Fresenius Medical Care AG (FMS) - Dividend Yield: 2.3%
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides pharmacy services, vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2019, it operated 3,994 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Volume
Today's last reported volume for Fresenius Medical Care AG is 672277, 74.63% above its average volume of 384982.
Fresenius Medical Care AG's last close was $33.80, 21.99% below its 52-week high of $43.33.
Fresenius Medical Care AG's Sales
Fresenius Medical Care AG's sales growth is a negative 5% for the ongoing quarter and 27.6% for the next. The company's growth estimates for the current quarter and the next is a negative 26% and a negative 24.7%, respectively.
Fresenius Medical Care AG's Revenue
Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Fresenius Medical Care AG's stock is considered to be oversold (<=20).
Fresenius Medical Care AG's Stock Yearly Top and Bottom Value
Fresenius Medical Care AG's stock is valued at $33.80 at 19:15 EST, way below its 52-week high of $43.33 and way higher than its 52-week low of $29.71.
Fresenius Medical Care AG's Moving Average
Fresenius Medical Care AG's worth is above its 50-day moving average of $33.36 and way under its 200-day moving average of $37.59.More news about Fresenius Medical Care AG.